Nausea Management

Nausea management is the clinical assessment and treatment of nausea, an unpleasant sensation that may precede vomiting and arise from gastrointestinal, neurologic, metabolic, medication-related, or psychological causes. Effective care begins by identifying and addressing the underlying trigger while supporting hydration, correcting electrolyte disturbances, and reducing signals from pathways that coordinate emesis, including serotonin, dopamine, histamine, and neurokinin receptors. Depending on the cause and severity, clinicians may use dietary adjustments, fluid replacement, behavioral measures, or antiemetic medications selected for their mechanism and safety profile. Appropriate management can prevent complications such as dehydration, improve comfort, and guide treatment of the underlying illness.

Nausea Management - Related Videos

Education

JoVE Core - Pharmacology

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

0 Views •

2024

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

0 Views •

2024

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy. Two synthetic agonists of THC,...

Early Intervention and Pain Management

0 Views •

2026

All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Monitoring Animals for Signs of Pain and Distress Recognizing early signs of pain is essential for ethical animal research. Animals are routinely monitored using behavioral, physical, and physiological parameters that reflect...

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

0 Views •

2024

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties. Phenothiazines, such as prochlorperazine...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

0 Views •

2024

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...

View All Results

FAQs

Related Topics